You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temsirolimus

Showing 26 - 50 of 142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in Chicago, Saint Louis

Completed
Has Results
  • Recurrent Breast Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • Temsirolimus
  • Chicago, Illinois
  • +1 more
Feb 13, 2020

Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma Trial in Worldwide (drug,

Suspended
  • Alveolar Rhabdomyosarcoma
  • +5 more
  • Birmingham, Alabama
  • +386 more
Aug 18, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Active, not recruiting
Has Results
  • Endometrial Adenocarcinoma
  • +9 more
  • Bevacizumab
  • +5 more
  • Phoenix, Arizona
  • +232 more
Jan 12, 2023

Kidney Cancer Trial in Grenoble (CK2 and ATM inhibitors serine/ threonin Kinase combination, Sunitinib, Pazopanib)

Recruiting
  • Kidney Cancer
  • CK2 and ATM inhibitors serine/ threonin Kinase combination
  • +3 more
  • Grenoble, France
    Grenoble Alps Hospital
Jan 16, 2020

Non-Hodgkins Lymphoma Trial in United States (Velcade, Temsirolimus)

Completed
Has Results
  • Non-Hodgkins Lymphoma
  • Rapid City, South Dakota
  • +17 more
Dec 11, 2019

Prostate Cancer Trial in Cleveland, Willoughby Hills (drug, biological, genetic, other)

Completed
Has Results
  • Prostate Cancer
  • temsirolimus
  • +3 more
  • Cleveland, Ohio
  • +2 more
Aug 19, 2019

Healthy Trial in Dallas (Lenalidomide, Quinidine, Temsirolimus)

Completed
  • Healthy
  • Dallas, Texas
    Covance Clinical Research Unit Dallas
Nov 6, 2019

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Cixutumumab
  • +2 more
  • Chicago, Illinois
  • +3 more
May 21, 2019

Advanced Cancer Trial in Houston (Doxil, Bevacizumab, Temsirolimus)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 9, 2019

Solid Tumor Trial in Philadelphia (drug, other, procedure)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 12, 2019

Non-Hodgkin's Lymphoma Trial in Worldwide (temsirolimus)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • temsirolimus
  • Miami, Florida
  • +30 more
May 17, 2019

Recurrent Endometrial Carcinoma Trial in United States (bevacizumab, temsirolimus)

Completed
Has Results
  • Recurrent Endometrial Carcinoma
  • bevacizumab
  • temsirolimus
  • Hartford, Connecticut
  • +40 more
Jul 19, 2019

PRETEXT Stage 1 Hepatoblastoma, PRETEXT Stage 2 Hepatoblastoma, PRETEXT Stage 3 Hepatoblastoma Trial in Worldwide (drug, other,

Active, not recruiting
Has Results
  • PRETEXT Stage 1 Hepatoblastoma
  • +3 more
  • Birmingham, Alabama
  • +208 more
Jan 25, 2023

Tumors, Malignant Carcinoma Trial in Boston, Villejuif (Neratinib, Temsirolimus)

Completed
Has Results
  • Neoplasms
  • Malignant Carcinoma
  • Boston, Massachusetts
  • +4 more
Aug 17, 2018

Temsirolimus Drug Use Investigation

Completed
  • Renal Cell Carcinoma
  • Temsirolimus
  • Fukuoka-shi, Fukuoka PREF, Japan
    Kyusyu University Hospital
Sep 14, 2018

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Advanced Solid Tumor Trial in Los Angeles, Rockland, Houston (Pimasertib, Temsirolimus)

Terminated
Has Results
  • Advanced Solid Tumor
  • Los Angeles, California
  • +2 more
Oct 25, 2017

Breast Cancer Trial in Worldwide (Temsirolimus, Neratinib)

Completed
Has Results
  • Breast Cancer
  • Goodyear, Arizona
  • +11 more
Aug 29, 2018

Endometrial Carcinoma, Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer Trial in United States (Laboratory

Completed
Has Results
  • Endometrial Carcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Burbank, California
  • +107 more
Jul 19, 2019

Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Japan, Korea, Republic of,

Completed
Has Results
  • Ovarian Clear Cell Cystadenocarcinoma
  • +2 more
  • Phoenix, Arizona
  • +144 more
Aug 6, 2019

Brain and CNS Tumors Trial in Worldwide (temozolomide, temsirolimus)

Completed
  • Brain and Central Nervous System Tumors
  • Leuven, Belgium
  • +12 more
Jul 6, 2018

Carcinoma, Renal Cell Trial in Houston (Sunitinib, Temsirolimus, Sorafenib)

Terminated
Has Results
  • Carcinoma, Renal Cell
  • Houston, Texas
    UTHealth Memorial Hermann Cancer Center
Sep 12, 2018

Brain and CNS Tumors, Metastatic Cancer Trial in Duarte (temsirolimus, pharmacological study, cytokine levels)

Completed
  • Brain and Central Nervous System Tumors
  • Metastatic Cancer
  • temsirolimus
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Apr 12, 2018

HER2-mutant NSCLC Trial in France, United States (neratinib, temsirolimus)

Completed
Has Results
  • HER2-mutant Non-Small Cell Lung Cancer
  • Duarte, California
  • +20 more
May 31, 2018

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
Has Results
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Bevacizumab
  • Temsirolimus
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019